5.0
23 May 2022
Recommend
CEO approval
Business outlook
Pros
Innovative, high impact, good people to work with, blue ocean commercially, a potential pipeline of product
Cons
Startup funding and uncertainties, diagnostics side is challenging, requires more research (not university spin-off), a new imaging platform with no traction, requires continuous access to patients during the R&D process
